Darifenacin Hydrobromide extended Release IP 7.5
Nov 02, 2022
Derifenac 7.5
Darifenacin Hydrobromide extended Release IP 7.5 is used to treat an overactive bladder. By relaxing the muscles in the bladder, Darifenacin Hydrobromide extended Release IP 7.5 improves your ability to control your urination. Darifenacin Hydrobromide extended Release IP 7.5 helps to reduce leaking of urine, feelings of needing to urinate right away, and frequent trips to the bathroom.
For more information please contact:
Recent Post
Sitagliptin Phosphate (50mg) & Metformin HCl (500mg) – Uses, Benefits, and Dosage
Magaldrate & Simethicone Oral Suspension in STERIS ANTACID MSO.
Calcium Polystyrene Sulphonate Powder: Mechanism of Action and Side Effects.
Lymecycline Capsules bp 408 mg Tablet From Steris healthcare.
Managing Type 2 Diabetes with Gliclazide (40mg) and Metformin (500mg)
Tolvaptan 15mg: Uses, Dosage, Side Effects, and Benefits
Understanding Repaglinide 0.5mg: A Guide to Managing Type 2 Diabetes
Fluvoxamine (50mg): Understanding Its Mechanism of Action and Impact on Mental Health
Managing Gastroesophageal Reflux Disease with Domperidone 30mg and Pantoprazole 40mg
Carbimazole 5mg: Side Effects, Dosage Instructions, and Potential Interactions